AFP and medical procedure: 79% AFP (21% PSZ, 38% micafungin, 13% ISA, 4% VCZ), 21% no AFP;12.6% probable/proven b-IFDs, the median time from initiating VEN–HMAs to the onset of IFDs was 107 days in responders and 66 days in non-responders to HMAs;Not available;Seven proven IFDs: two Scedosporium spp. (one fungemia, one skin-deep tissue), three mucormycosis (one disseminated, two sinus-orbit), one IPA, one disseminated Aspergillus-Mucor coinfection;Eight probable IFDs: five IPA, one unspecified mold lung infection, one lung mucormycosis, one Penicillium spp. pneumonia.